Image 1 of 1
Image 1 of 1
Image 1 of 1
Image 1 of 1
GLP-3 is an informal term commonly used to describe next-generation triple-receptor agonist peptides, such as retatrutide, that simultaneously target the GLP-1, GIP, and glucagon receptors. These pathways are being studied for their roles in glucose regulation, appetite signaling, energy expenditure, lipid metabolism, and overall metabolic function.
Triple-agonist compounds remain an active area of scientific research, with studies investigating how simultaneous activation of multiple metabolic pathways may differ from single- or dual-receptor agonists.
For Research Use Only. Not for Human Consumption.
This product is intended strictly for laboratory and scientific research purposes and is not intended to diagnose, treat, cure, or prevent any disease.
GLP-3 is an informal term commonly used to describe next-generation triple-receptor agonist peptides, such as retatrutide, that simultaneously target the GLP-1, GIP, and glucagon receptors. These pathways are being studied for their roles in glucose regulation, appetite signaling, energy expenditure, lipid metabolism, and overall metabolic function.
Triple-agonist compounds remain an active area of scientific research, with studies investigating how simultaneous activation of multiple metabolic pathways may differ from single- or dual-receptor agonists.
For Research Use Only. Not for Human Consumption.
This product is intended strictly for laboratory and scientific research purposes and is not intended to diagnose, treat, cure, or prevent any disease.